3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)-
|
|
- CAS-Nr.
- 151213-15-9
- Englisch Name:
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)-
- Synonyma:
- Mosisasin ImpurityA;Moxifloxacin impurity A;Moxifloxacin Imp. A RS IP;Moxifloxacin EP IMpurity A;Moxifloxacin IMp. A (EP,BP);Moxifloxacin Impurity A(EP);Moxifloxacin Difluoro Analog;Moxifloxacin HCl Impurity A;Moxifloxacin Related Matter 1;Moxifloxacin Related Matter A
- CBNumber:
- CB31448424
- Summenformel:
- C20H21F2N3O3
- Molgewicht:
- 389.4
- MOL-Datei:
- 151213-15-9.mol
|
3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)- Eigenschaften
- Schmelzpunkt:
- 247-249°C
- Siedepunkt:
- 596.9±50.0 °C(Predicted)
- Dichte
- 1.468±0.06 g/cm3(Predicted)
- storage temp.
- Keep in dark place,Inert atmosphere,2-8°C
- L?slichkeit
- Chloroform (Slightly, Heated. Sonicated), Methanol (Slightly, Heated, Sonicated)
- Aggregatzustand
- Solid
- pka
- 6.41±0.50(Predicted)
- Farbe
- Pale Yellow to Pale Green
- Wasserl?slichkeit
- 2.5g/L at 20℃
- Stabilit?t:
- Hygroscopic
- LogP
- -0.5 at 23℃
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
|
|
Sicherheit |
P261 |
Einatmen von Staub vermeiden. |
P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)- Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Pale Yellow Solid
3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)- Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 140)Lieferanten
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)-
- 8-Desmethoxy-8-fluoro Moxifloxacin
- 1-Cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- Moxifloxacin Related CoMpound A
- Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-
- Moxifloxacin related substance A
- 1-Cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid
- Moxifloxacin IMp. A (EP,BP)
- Moxifloxacin Hydrochloride IMpurity-A(EP)(USPRC A)
- Moxifloxacin EP IMpurity A
- 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo-[3,4-b]pyridin-6(2H)-yl)-4-oxo-1
- Moxifloxacin impurity A
- Moxifloxacin Imp. A RS IP
- 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
- Moxifloxacin Related Matter 1
- 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo-[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-d
- USP Moxifloxacin Related Compound A
- Moxifloxacin EP Impurity A/ Moxifloxacin Related Compound A (Moxifloxacin Difluoro Analog)
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-d...
- Moxifloxacin Related Compound A (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-p (1448617)
- Moxifloxacin Difluoro Analog
- Moxifloxacin hydrochloride impurity A
- 1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
- Moxifloxacin Related Matter A
- Moxifloxacin EP Impurity A : Moxifloxacin Impurity A
- Moxifloxacin EP Impurity A HCl USP/EP/BP
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)- USP/EP/BP
- 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6,8-difluoro-4-oxoquinoline-3-carboxylic acid
- 1-cyclopropyl-6-fluoro-7-amino-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-7-amino-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 7-amino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxoquinoline-3-carboxylic acid
- Moxifloxacin impurity 2/Moxifloxacin EP Impurity A HCl/Moxifloxacin Difluoro Analog HCl/8-Desmethoxy-8-fluoro Moxifloxacin HCl/1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Hydrochloride
- Moxifloxacin impurity 1/Moxifloxacin EP Impurity A/Moxifloxacin Difluoro Analog/8-Desmethoxy-8-Fluoro Moxifloxacin/1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 8-Ddesmethoxy-8-fluoroMoxifloxacin
- Mosisasin ImpurityA
- Moxifloxacin USP Related Compound A
- Moxifloxacin Hydrochloride EP Impurity A
- Moxifloxacin Impurity A(EP)
- Moxifloxacin Impurity A(Moxifloxacin hydrochloride EP impurity A)
- Moxifloxacin HCl EP Impurity-A
- Moxifloxacin EP Impurity A
Moxifloxacin USP RC A
- Moxifloxacin HCl Impurity A
- 7-[(4aS,7aS)-1,2,4a,5,7,7a-hexahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6,8-difluoro-4-oxo-3H-quinoline-3-carboxylic acid
- 1-Cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroqu
- 151213-15-9
- Chiral Reagents
- Heterocycles
- Impurities
- Intermediates & Fine Chemicals
- Pharmaceuticals